Acurx Pharmaceuticals Shines in Bloomberg’s “New To The Street” Visionaries Series Premiere

Acurx Pharmaceuticals Shines in Bloomberg’s “New To The Street” Visionaries Series Premiere

“`html Acurx Pharmaceuticals‘ Journey to Be Spotlighted on Bloomberg’s Visionaries Series Acurx Pharmaceuticals’ Journey to Be Spotlighted on bloomberg’s Visionaries series Table of Contents Acurx Pharmaceuticals’ Journey to Be Spotlighted on bloomberg’s Visionaries series From College to Biotech: the Acurx Pharmaceuticals Story Addressing Global Health Challenges with Innovative Treatments The Founding Team: A Synergistic Blend … Read more

Acurx Pharmaceuticals Lands Japanese Patent for Groundbreaking DNA Polymerase IIIC Inhibitors in Cancer Treatment

Acurx Pharmaceuticals Lands Japanese Patent for Groundbreaking DNA Polymerase IIIC Inhibitors in Cancer Treatment

Acurx Pharmaceuticals‘ Ibezapolstat Advances too Phase 3 Trials After Securing Japanese Patent Table of Contents Acurx Pharmaceuticals’ Ibezapolstat Advances too Phase 3 Trials After Securing Japanese Patent Phase 2 Clinical Trial Results About Ibezapolstat and CDI About Acurx Pharmaceuticals,Inc. Revolutionary Antibiotic Breakthrough: Acutious Pharmaceuticals’ Ibezapolstat Spearheads teh Battle against Antibiotic Resistance The Turning Point in … Read more